FONDAPARINUX (FON da PAR in ux) is used after knee, hip, or abdominal surgeries to prevent blood clotting. It is also used to treat existing blood clots in the lungs or in the veins.
Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor. Apart from the O-
methyl group at the reducing end of the molecule, the identity and sequence of ...
Physician reviewed fondaparinux patient information - includes fondaparinux
description, dosage and directions.
Medscape - Indication-specific dosing for Arixtra (fondaparinux), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
Learn about the prescription medication Arixtra (Fondaparinux Sodium), drug
uses, dosage, side effects, drug interactions, warnings, reviews and patient ...
Find patient medical information for fondaparinux subcutaneous on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and
Sep 29, 2014 ... The recommended dose of fondaparinux is 2.5 mg once daily administered by
subcutaneous injection. A treatment duration of 6-14 days has ...
Feb 17, 2015 ... Importance Fondaparinux was associated with reduced major bleeding events
and improved survival compared with low-molecular-weight ...
Fondaparinux is a promising new antithrombotic agent. This pentasaccharide
selectively and specifically inhibits coagulation factor Xa, and requires ...
Apr 16, 2014 ... Consumer information about the medication FONDAPARINUX - INJECTION (
Arixtra), includes side effects, drug interactions, recommended ...